L-Tartaric Acid Shows Promise for Diabetic Cardiomyopathy
Pre-clinical trials showed long-term L-tartaric acid treatment improved cardiac function and was associated with reduced inflammation, oxidative stress, and apoptosis in diabetic cardiomyopathy.